Alissa S Marr, MD | Nebraska Medicine ...

Dr. Alissa S. Marr

Claim this profile

University of Nebraska Medical Center

Studies Cancer
Studies Melanoma
7 reported clinical trials
31 drugs studied

Area of expertise

1

Cancer

Alissa S. Marr has run 3 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
2

Melanoma

Alissa S. Marr has run 3 trials for Melanoma. Some of their research focus areas include:

Stage III
Stage IV
BRAF positive

Affiliated Hospitals

Image of trial facility.

University Of Nebraska Medical Center

Image of trial facility.

Nebraska Medicine-Village Pointe

Clinical Trials Alissa S. Marr is currently running

Image of trial facility.

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Recruiting

1 award

Phase 2

9 criteria

Image of trial facility.

Data Collection

for Cancer Immunotherapy Side Effects

This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.

Recruiting

1 award

N/A

7 criteria

More about Alissa S. Marr

Clinical Trial Related

5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Alissa S. Marr has experience with

  • Talazoparib
  • Nivolumab
  • Atezolizumab And PHESGO
  • Futibatinib
  • Sunitinib
  • Regorafenib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Alissa S. Marr specialize in?

Is Alissa S. Marr currently recruiting for clinical trials?

Are there any treatments that Alissa S. Marr has studied deeply?

What is the best way to schedule an appointment with Alissa S. Marr?

What is the office address of Alissa S. Marr?

Is there any support for travel costs?